NBE-Therapeutics raised €2.8M in a Series A round in Mar 2015. The company is based in Basel, Switzerland. Investors in the round: Boehringer Ingelheim Venture Fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.8M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
